A clinical trial study to determine the role of chemical thrombo-prophylaxis in patients undergoing arthroscopic anterior cruciate ligament reconstructive surgery
- Conditions
- Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
- Registration Number
- CTRI/2021/06/034419
- Lead Sponsor
- Dinshaw Pardiwala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1Patients undergoing arthroscopic ACL reconstruction (with or without associated meniscus or chondral surgery)
2.Age group 16 to 60 year
3Gender Male and female patients will be included
4Patients who would voluntarily agree to sign informed consent form
5.Patients who would be available to perform the postoperative color Doppler evalua-tion at KDAH.
1Patients undergoing arthroscopic ACL reconstruction associated with other ligament re-constructive surgery that is arthroscopic bicruciate reconstructions and multiple ligament reconstructions
2Age group : <16 years & >60 years
3Patients diagnosed with acute or chronic DVT on preoperative venous color Doppler
4Patients having a high risk of DVT which would under normal circumstances warrant mandatory chemical thromboprophylaxis including previous history of DVT or PE, his-tory of recent malignancy (within the past 12 months), pregnancy, or patients on oral contraceptives.
5History of thrombophilic conditions
6A patient having more than 3 risk factors for developing DVT would be excluded. These include : smoking, nicotine abuse, hormonal replacement therapy, antipsychotic treatment, varicose vein, family history of thrombosis, ongoing treatment with steroids, anticoagulant or antiplatelet agents, history of gastrointestinal bleeding in the past 2 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method